|
891 |
Influence of remnant cholesterol on direct LDL and HDL cholesterol measurement accuracy
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 2: 432-444. 13 S.
|
|
|
|
892 |
Staining and serological characteristics of the AC-30 pattern in HEp-2 IIFA: a comparative study with AC-2 pattern
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 2: 401-409. 09 S.
|
|
|
|
893 |
Estimated waste generation from 1 million basic metabolic panels: a multisite U.S. study
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 2: 361-367. 07 S.
|
|
|
|
894 |
Requiem for the Passing–Bablok nonparametric regression in assessing the agreement between two measurement methods
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 2: 343-352. 10 S.
|
|
|
|
895 |
Failure Mode and Effects Analysis (FMEA) integrating quality indicators for risk assessment of the total testing process in human papillomavirus genotyping testing: a proactive risk analysis model for molecular diagnostics
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 2: 305-331. 27 S.
|
|
|
|
896 |
Comparative analysis of aggregate gradation variation in porous asphalt mixtures under different compaction methods 1
Enthalten in Reviews on advanced materials science Bd. 64, 2026, Nr. 1. 18 S.
|
|
|
|
897 |
Proadrenomedullin for prediction of early and mid-term mortality in patients hospitalized for community-acquired pneumonia
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 1: 250-259. 10 S.
|
|
|
|
898 |
Analysis of total cholesterol results measured in the initial period of the Croatian screening program for familial hypercholesterolemia: a pilot study
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 1: 215-224. 10 S.
|
|
|
|
899 |
An automatic chemiluminescence immunoassay for a novel biomarker NT-IGFBP-4: analytical performance and clinical relevance in heart failure
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 1: 205-214. 10 S.
|
|
|
|
900 |
Defining the analytical characteristics of a novel high-sensitivity point-of-care troponin I assay in its intended clinical environment
Enthalten in Clinical chemistry and laboratory medicine Bd. 64, 2026, Nr. 1: 194-204. 11 S.
|
|
Administration
